BACKGROUND: Hexokinase I sets the pace of glycolysis in the brain, catalyzing the ATP-dependent phosphorylation of glucose. The catalytic properties of hexokinase I are dependent on product inhibition as well as on the action of phosphate. In vivo, a large fraction of hexokinase I is bound to the mitochondrial outer membrane, where the enzyme adopts a tetrameric assembly. The mitochondrion-bound hexokinase I is believed to optimize the ATP/ADP exchange between glucose phosphorylation and the mitochondrial oxidative phosphorylation reactions. RESULTS: The crystal structure of human hexokinase I has been determined at 2.25 A resolution. The overall structure of the enzyme is in keeping with the closed conformation previously observed in yeast hexokinase. One molecule of the ATP analogue AMP-PNP is bound to each N-terminal domain of the dimeric enzyme in a surface cleft, showing specific interactions with the nucleotide, and localized positive electrostatic potential. The molecular symmetry brings the two bound AMP-PNP molecules, at the centre of two extended surface regions, to a common side of the dimeric hexokinase I molecule. CONCLUSIONS: The binding of AMP-PNP to a protein site separated from the catalytic centre of human hexokinase I can be related to the role played by some nucleotides in dissociating the enzyme from the mitochondrial membrane, and helps in defining the molecular regions of hexokinase I that are expected to be in contact with the mitochondrion. The structural information presented here is in keeping with monoclonal antibody mapping of the free and mitochondrion-bound forms of the enzyme, and with sequence analysis of hexokinases that differ in their mitochondria binding properties.
BACKGROUND:Hexokinase I sets the pace of glycolysis in the brain, catalyzing the ATP-dependent phosphorylation of glucose. The catalytic properties of hexokinase I are dependent on product inhibition as well as on the action of phosphate. In vivo, a large fraction of hexokinase I is bound to the mitochondrial outer membrane, where the enzyme adopts a tetrameric assembly. The mitochondrion-bound hexokinase I is believed to optimize the ATP/ADP exchange between glucose phosphorylation and the mitochondrial oxidative phosphorylation reactions. RESULTS: The crystal structure of humanhexokinase I has been determined at 2.25 A resolution. The overall structure of the enzyme is in keeping with the closed conformation previously observed in yeasthexokinase. One molecule of the ATP analogue AMP-PNP is bound to each N-terminal domain of the dimeric enzyme in a surface cleft, showing specific interactions with the nucleotide, and localized positive electrostatic potential. The molecular symmetry brings the two bound AMP-PNP molecules, at the centre of two extended surface regions, to a common side of the dimeric hexokinase I molecule. CONCLUSIONS: The binding of AMP-PNP to a protein site separated from the catalytic centre of humanhexokinase I can be related to the role played by some nucleotides in dissociating the enzyme from the mitochondrial membrane, and helps in defining the molecular regions of hexokinase I that are expected to be in contact with the mitochondrion. The structural information presented here is in keeping with monoclonal antibody mapping of the free and mitochondrion-bound forms of the enzyme, and with sequence analysis of hexokinases that differ in their mitochondria binding properties.
Authors: Vladimir V Lunin; Yunge Li; Joseph D Schrag; Pietro Iannuzzi; Miroslaw Cygler; Allan Matte Journal: J Bacteriol Date: 2004-10 Impact factor: 3.490
Authors: Lori S Sullivan; Daniel C Koboldt; Sara J Bowne; Steven Lang; Susan H Blanton; Elizabeth Cadena; Cheryl E Avery; Richard A Lewis; Kaylie Webb-Jones; Dianna H Wheaton; David G Birch; Razck Coussa; Huanan Ren; Irma Lopez; Christina Chakarova; Robert K Koenekoop; Charles A Garcia; Robert S Fulton; Richard K Wilson; George M Weinstock; Stephen P Daiger Journal: Invest Ophthalmol Vis Sci Date: 2014-09-04 Impact factor: 4.799
Authors: Shanti Swaroop Srivastava; Joseph E Darling; Jimmy Suryadi; James C Morris; Mark E Drew; Sriram Subramaniam Journal: IUCrJ Date: 2020-03-26 Impact factor: 4.769
Authors: Helmut Bischof; Sandra Burgstaller; Anna Springer; Lucas Matt; Thomas Rauter; Olaf A Bachkönig; Tony Schmidt; Klaus Groschner; Rainer Schindl; Tobias Madl; Nikolaus Plesnila; Robert Lukowski; Wolfgang F Graier; Roland Malli Journal: iScience Date: 2021-03-22